These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 24764358)

  • 21. Small-size recombinant adenoviral hexon protein fragments for the production of virus-type specific antibodies.
    Pacesa M; Hendrickx R; Bieri M; Flatt JW; Greber UF; Hemmi S
    Virol J; 2017 Aug; 14(1):158. PubMed ID: 28821267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel human monoclonal antibody potently neutralizes human adenovirus serotype 7 by primarily targeting the adenovirus hexon protein.
    Lu J; Wang R; Huang Y; Yu Y; Zhou X; Huang P; Yang Z
    Virology; 2020 Apr; 543():20-26. PubMed ID: 32056843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neutralizing antibodies against adenovirus type 2 in normal and HIV-1-infected subjects: Implications for use of Ad2 vectors in vaccines.
    Li Q; Liu Q; Huang W; Song A; Zhao C; Wu J; Wang Y
    Hum Vaccin Immunother; 2017 Jun; 13(6):1-8. PubMed ID: 28301274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A serological survey of human adenovirus serotype 2 and 5 circulating pediatric populations in Changchun, China, 2011.
    Yu B; Wang Z; Dong J; Wang C; Gu L; Sun C; Kong W; Yu X
    Virol J; 2012 Nov; 9():287. PubMed ID: 23176136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a nonstructural DNA-binding protein (DBP) as an antigen with diagnostic potential for human adenovirus.
    Guo L; Wu C; Zhou H; Wu C; Paranhos-Baccalà G; Vernet G; Jin Q; Wang J; Hung T
    PLoS One; 2013; 8(3):e56708. PubMed ID: 23516396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of serum neutralizing antibodies to adenovirus type 5 (Ad5) and 41 (Ad41) in children is associated with age and sanitary conditions.
    Yang WX; Zou XH; Jiang SY; Lu NN; Han M; Zhao JH; Guo XJ; Zhao SC; Lu ZZ
    Vaccine; 2016 Nov; 34(46):5579-5586. PubMed ID: 27682509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Seroprevalence of neutralizing antibodies to adenovirus type 5 among children in India: implications for recombinant adenovirus-based vaccines.
    Appaiahgari MB; Pandey RM; Vrati S
    Clin Vaccine Immunol; 2007 Aug; 14(8):1053-5. PubMed ID: 17596429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antigenic sites on the receptor-binding domain of human adenovirus type 2 fiber.
    Fender P; Kidd AH; Brebant R; Oberg M; Drouet E; Chroboczek J
    Virology; 1995 Dec; 214(1):110-7. PubMed ID: 8525605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adenovirus-based vaccines: comparison of vectors from three species of adenoviridae.
    Chen H; Xiang ZQ; Li Y; Kurupati RK; Jia B; Bian A; Zhou DM; Hutnick N; Yuan S; Gray C; Serwanga J; Auma B; Kaleebu P; Zhou X; Betts MR; Ertl HC
    J Virol; 2010 Oct; 84(20):10522-32. PubMed ID: 20686035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A tetravalent vaccine comprising hexon-chimeric adenoviruses elicits balanced protective immunity against human adenovirus types 3, 7, 14 and 55.
    Tian X; Jiang Z; Fan Y; Qiu S; Zhang L; Li X; Zhou Z; Liu T; Ma Q; Lu X; Zhong B; Zhou R
    Antiviral Res; 2018 Jun; 154():17-25. PubMed ID: 29626491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changing the adenovirus fiber for retaining gene delivery efficacy in the presence of neutralizing antibodies.
    Särkioja M; Pesonen S; Raki M; Hakkarainen T; Salo J; Ahonen MT; Kanerva A; Hemminki A
    Gene Ther; 2008 Jun; 15(12):921-9. PubMed ID: 18401431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antigenic variability among two subtypes of human adenovirus serotype 7.
    Tian X; Su X; Xue C; Li X; Zhou Z; Zhou R
    Virus Genes; 2014 Aug; 49(1):22-9. PubMed ID: 24760574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neutralizing epitopes mapping of human adenovirus type 14 hexon.
    Ma Q; Tian X; Jiang Z; Huang J; Liu Q; Lu X; Luo Q; Zhou R
    Vaccine; 2015 Nov; 33(48):6659-65. PubMed ID: 26546264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reactivity of mouse ascitic fluids containing monoclonal antibodies directed against adenovirus hexon.
    Adám E; Erdei J; Lengyel A; Katona A; Berencsi G; Fachet J; Nász I
    Acta Microbiol Hung; 1985; 32(1):113-24. PubMed ID: 2412388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human Adenovirus Serotype 3 Vector Packaged by a Rare Serotype 14 Hexon.
    Su X; Tian X; Jiang Z; Ma Q; Liu Q; Lu X; Zhou R
    PLoS One; 2016; 11(6):e0156984. PubMed ID: 27328032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fiber-based fluorescent microsphere immunoassay (FMIA) as a novel multiplex serodiagnostic tool for simultaneous detection and differentiation of all clinically relevant fowl adenovirus (FAdV) serotypes.
    Feichtner F; Schachner A; Berger E; Hess M
    J Immunol Methods; 2018 Jul; 458():33-43. PubMed ID: 29522774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mapping of linear epitopes on fibre knob of human adenovirus serotype 5.
    Liebermann H; Lotz K; Mentel R; Bauer U; Seidel W
    Virus Res; 2001 Mar; 73(2):145-51. PubMed ID: 11172918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Seroprevalence of Neutralizing Antibodies against Human Adenovirus Type-5 and Chimpanzee Adenovirus Type-68 in Cancer Patients.
    Zhao H; Xu C; Luo X; Wei F; Wang N; Shi H; Ren X
    Front Immunol; 2018; 9():335. PubMed ID: 29563911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A mosaic adenovirus possessing serotype Ad5 and serotype Ad3 knobs exhibits expanded tropism.
    Takayama K; Reynolds PN; Short JJ; Kawakami Y; Adachi Y; Glasgow JN; Rots MG; Krasnykh V; Douglas JT; Curiel DT
    Virology; 2003 May; 309(2):282-93. PubMed ID: 12758175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Receptor binding sites and antigenic epitopes on the fiber knob of human adenovirus serotype 3.
    Liebermann H; Mentel R; Bauer U; Pring-Akerblom P; Dölling R; Modrow S; Seidel W
    J Virol; 1998 Nov; 72(11):9121-30. PubMed ID: 9765458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.